DexCom Other accrued liabilities increased by 5.9% to $48.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $50.30M to $48.50M. Over 4 years (FY 2020 to FY 2025), Other accrued liabilities shows relatively stable performance with a 1.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Significant increases may indicate rising operational costs or changes in accounting accruals.
Miscellaneous short-term obligations that do not fall into standard categories like accounts payable or debt. These ofte...
Varies widely based on company-specific accounting policies and operational structure.
other_other_accrued_liabilities_current| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $49.60M | $48.10M | $39.70M | $37.80M | $47.50M | $40.50M | $46.40M | $37.10M | $36.70M | $37.10M | $50.30M | $42.60M | $42.00M | $45.80M | $48.50M |
| QoQ Change | — | -3.0% | -17.5% | -4.8% | +25.7% | -14.7% | +14.6% | -20.0% | -1.1% | +1.1% | +35.6% | -15.3% | -1.4% | +9.0% | +5.9% |
| YoY Change | — | — | — | — | — | +2.0% | — | -1.9% | -22.7% | -8.4% | +8.4% | +14.8% | +14.4% | +23.5% | -3.6% |